Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
BRIDGEBIO PHARMA INC
CUSIP: 10806XAD4
Class: Convertible Debt
RWC Asset Management LLP's Holding History (CIK: 0001520478)
Note: Option positions (PUT/CALL) are excluded.
Q4 2025
Shares
1,491,000
Value ($000)
$1,679
Avg Close
—
Range
—
Period
Shares
Value ($000)
Average Close
Price Range
Q4 2025
1,491,000
$1,679
—
—